ESCRS 2023: Integrated workflow solutions in cataract procedures

News
Video

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Euan Thomson, the President of Ophthalmic Devices, Carl Zeiss Meditec spoke with our team about integrated workflow solutions and how they can benefit cataract procedures while at the 2023 ESCRS meeting in Vienna, Austria.

Video Transcript

Editor's note - This transcript has been edited for clarity.

Euan Thomson: So I'm Euan Thompson, I'm President of Ophthalmology at Carl Zeiss, and Head of Digital Business. You know, we're working very hard on creating integrated workflow solutions. This is a big theme for us. And I think that, as people go around our booth, there's actually going to be a high level of integration that we've already been able to achieve.

Some of our workflows are complete; cataract workflow, for example, is there. And we've actually been able to demonstrate the value of this to customers. So we're really targeting new value propositions beyond the technology itself. We're really looking at efficiency gains in the operating room efficiency gains in the run up to a treatment. We're looking at quality improvement, standardization, and we're actually already gathering data on these. So we're really excited about that and really looking forward to showcasing it today.

So what I'm looking forward to in 2024, is really, really demonstrating the power of the level of integration that we've achieved, you know, our digitally connected workflows are really quite evolved now. The true value of those in terms of, you know, the efficiency gains and standardization and so on these new value propositions, being able to test those and getting the data back is really exciting, you know. A cataract workflow, we've actually now got demonstrable data that shows that there is a true efficiency gain, not just in the run up to a treatment but in the operating room itself. And it can be as high as 30% timesaving in the operating room for some procedures. So this is meaningful improvements in the standard of care.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.